In diabetes, pancreatic β‐cells were still able to respond to GLP‐1, making GLP‐1 an attractive therapeutic for diabetes and leaving GIP to become known as the “forgotten incretin.”13 However GIP, not GLP‐1, has a direct effect on bone. This evidence concerns the gene GIP and diabetes mellitus.